Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0 (APPOINT 2.0): A Multi-center Randomized Controlled Trial
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 15 Years to 45 Years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study tests whether antibiotics given during labor can lower the chance of a C-section (surgery to deliver a baby). It is for pregnant women with obesity who have not given birth at 20 weeks or later and are having labor started with medical help at 37 weeks or later.
Obesity increases the risk of pregnancy complications, including puerperal infections and cesarean delivery, and risk rises with increasing body mass index (BMI). Since obese women are more likely to have comorbidities that would necessitate delivery prior to their due date (i.e. prior to 40 weeks gestation), and class III obesity specifically is an indication for delivery by 39 weeks, these patients have a high rate of labor induction. In nulliparous women from the general population (obese and non-obese), labor induction at 39 weeks (compared to expectant management) is associated with less maternal morbidity and a lower cesarean rate. Researchers previously conducted a pilot randomized placebo-controlled trial in obese, nulliparous women undergoing labor induction at term and found that the cesarean delivery rate was lower in women who received a prophylactic antibiotic regimen during labor compared with those who received the placebo. Researchers proposed multi-center trial aims to test this hypothesis in a large sample with adequate power to determine whether prophylactic antibiotics during labor are associated with a decrease in the rate of cesarean delivery in term, nulliparous, obese women. If the findings from the pilot trial are confirmed, this would represent a novel intervention to decrease the cesarean delivery rate in a subset of women at highest risk for cesarean-related complications.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Have a body mass index (BMI), a measure of body size, of 30 or higher.
- Have never given birth at 20 weeks of pregnancy or later.
- Are having labor started with medical help.
- Are at least 37 weeks pregnant.
- Are 15 to 45 years old.
- Are not getting antibiotics during labor to prevent group B strep (GBS), a bacterial infection.
Who can't join
- The baby died before labor was started.
- The baby has a known birth defect.
- Are pregnant with more than one baby.
- Your water has been broken for more than 12 hours.
- Have an infection around the baby, or another infection needing antibiotics, when labor is started.
- Have had surgery on the muscle wall of the uterus (womb).
- Are allergic to azithromycin or beta-lactam antibiotics.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * BMI ≥30 * No prior deliveries at or beyond 20 weeks gestation * Undergoing induction of labor * Gestational age 37 weeks or more * Age 15-45 * Not receiving IAP for GBS prophylaxis Exclusion Criteria: * Fetal death prior to labor induction * Known fetal anomaly * Multiple gestation * Ruptured membranes for more than 12 hours * Chorioamnionitis or other infection requiring antibiotics at the start of the labor induction * Previous myometrial surgery * Allergy to azithromycin or beta-lactam antibiotics
Study sites (1)
OK
- University of Oklahoma Health Sciences Center · Oklahoma City, OK 73104Christy Zornes, MHR · Study contact · 405-271-8001 ext. 48137 · christy-zornes@ouhsc.eduKyra Woods, BA · Study contact · 405-271-8001 ext. 45750 · kyra-woods@ouhsc.eduStephanie Pierce, MD · Principal investigatorMore trials in Oklahoma City